← FDA Drug Approvals (Drugs@FDA)

VASOPRESSIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: FRESENIUS KABI USA · Approved 2023-05-26

Drug application

FDA Application #

ANDA213206

Application type

Abbreviated New Drug Application (Generic)

Brand name

VASOPRESSIN

Generic name

VASOPRESSIN

Active ingredients

VASOPRESSIN

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

FRESENIUS KABI USA

Manufacturer

Fresenius Kabi USA, LLC

First approval

2023-05-26

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown